1 |
Paoletti FP , Simoni S , Parnetti L , Gaetani L . The contribution of small vessel disease to neurodegeneration: focus on Alzheimer's disease, Parkinson's disease and multiple sclerosis. Int J Mol Sci, 2021, 22: 4958.
doi: 10.3390/ijms22094958
|
2 |
Lin CW , Lai TT , Chen SJ , Lin CH . Elevated α-synuclein and NfL levels in tear fluids and decreased retinal microvascular densities in patients with Parkinson's disease. GeroScience, 2022, 44: 1551- 1562.
doi: 10.1007/s11357-022-00576-6
|
3 |
Jeong SH , Lee HS , Jung JH , Baik K , Lee YH , Yoo HS , Sohn YH , Chung SJ , Lee PH . White matter hyperintensities, dopamine loss, and motor deficits in de novo Parkinson's disease. Mov Disord, 2021, 36: 1411- 1419.
doi: 10.1002/mds.28510
|
4 |
London A , Benhar I , Schwartz M . The retina as a window to the brain-from eye research to CNS disorders. Nat Rev Neurol, 2013, 9: 44- 53.
doi: 10.1038/nrneurol.2012.227
|
5 |
Hughes S , Yang H , Chan-Ling T . Vascularization of the human fetal retina: roles of vasculogenesis and angiogenesis. Invest Ophthalmol Vis Sci, 2000, 41: 1217- 1228.
|
6 |
Morgia CL , Vito LD , Carelli V , Carbonelli M . Patterns of retinal ganglion cell damage in neurodegenerative disorders: parvocellular vs magnocellular degeneration in optical coherence tomography studies. Front Neurol, 2017, 8: 710.
doi: 10.3389/fneur.2017.00710
|
7 |
Garzone D , Finger RP , Mauschitz MM , Koch A , Reuter M , Breteler MMB , Aziz NA . Visual impairment and retinal and brain neurodegeneration: a population-based study. Hum Brain Mapp, 2023, 44: 2701- 2711.
doi: 10.1002/hbm.26237
|
8 |
Parkinson's Disease and Movement Disorders Group, Neurology Branch, Chinese Medical Association , Parkinson's Disease and Movement Disorders Committee, Neurologist Branch, Chinese Medical Doctor Association . Diagnostic criteria for Parkinson's disease in China (2016 edition). Zhonghua Shen Jing Ke Za Zhi, 2016, 49: 268- 271.
doi: 10.3760/cma.j.issn.1006-7876.2016.04.002
|
|
中华医学会神经病学分会帕金森病及运动障碍学组, 中国医师协会神经内科医师分会帕金森病及运动障碍专业委员会. 中国帕金森病的诊断标准(2016版). 中华神经科杂志, 2016, 49: 268- 271.
doi: 10.3760/cma.j.issn.1006-7876.2016.04.002
|
9 |
Tomlinson CL , Stowe R , Patel S , Rick C , Gray R , Clarke CE . Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord, 2010, 25: 2649- 2653.
doi: 10.1002/mds.23429
|
10 |
Goetz CG , Tilley BC , Shaftman SR , Stebbins GT , Fahn S , Martinez-Martin P , Poewe W , Sampaio C , Stern MB , Dodel R , Dubois B , Holloway R , Jankovic J , Kulisevsky J , Lang AE , Lees A , Leurgans S , LeWitt PA , Nyenhuis D , Olanow CW , Rascol O , Schrag A , Teresi JA , Hilten JJV , LaPelle N , Movement Disorder Society UPDRS Revision Task Force . Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord, 2008, 23: 2129- 2170.
doi: 10.1002/mds.22340
|
11 |
Liu SY , Chen P . Epidemiology of Parkinson's disease. Zhongguo Xian Dai Shen Jing Ji Bing Za Zhi, 2016, 16: 98- 101.
doi: 10.3969/j.issn.1672-6731.2016.02.007
|
|
刘疏影, 陈彪. 帕金森病流行现状. 中国现代神经疾病杂志, 2016, 16: 98- 101.
doi: 10.3969/j.issn.1672-6731.2016.02.007
|
12 |
Tang LJ , Yue LC , Liu CX , Wu L , Peng YY . Current status and influencing factors of self-perceived burden in patients with Parkinson's disease. Zhongguo Lao Nian Xue Za Zhi, 2020, 40: 1986- 1989.
doi: 10.3969/j.issn.1005-9202.2020.09.059
|
|
唐浪娟, 岳丽春, 刘聪香, 吴利, 彭雨燕. 帕金森病患者自我感受负担现状及其影响因素. 中国老年学杂志, 2020, 40: 1986- 1989.
doi: 10.3969/j.issn.1005-9202.2020.09.059
|
13 |
Normando EM , Davis BM , Groef LD , Nizari S , Turner LA , Ravindran N , Pahlitzsch M , Brenton J , Malaguarnera G , Guo L , Somavarapu S , Cordeiro MF . The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson's disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol Commun, 2016, 4: 86.
doi: 10.1186/s40478-016-0346-z
|
14 |
Ortuño Lizarán I , Sánchez Sáez X , Lax P , Serrano GE , Beach TG , Adler CH , Cuenca N . Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann Neurol, 2020, 88: 893- 906.
doi: 10.1002/ana.25897
|
15 |
Veys L , Vandenabeele M , Ortuño-Lizarán I , Baekelandt V , Cuenca N , Moons L , Groef LD . Retinal α-synuclein deposits in Parkinson's disease patients and animal models. Acta Neuropathol, 2019, 137: 379- 395.
doi: 10.1007/s00401-018-01956-z
|
16 |
Bodis-Wollner I , Kozlowski PB , Glazman S , Miri S . α-synuclein in the inner retina in Parkinson disease. Ann Neurol, 2014, 75: 964- 966.
doi: 10.1002/ana.24182
|
17 |
Morgia CL , Ross-Cisneros FN , Sadun AA , Carelli V . Retinal ganglion cells and circadian rhythms in Alzheimer's disease, Parkinson's disease, and beyond. Front Neurol, 2017, 8: 162.
doi: 10.3389/fneur.2017.00162
|
18 |
Guo L , Normando EM , Shah PA , Groef LD , Cordeiro MF . Oculo-visual abnormalities in Parkinson's disease: possible value as biomarkers. Move Disord, 2018, 33: 1390- 1406.
doi: 10.1002/mds.27454
|
19 |
Huang F , Shu Z , Huang Q , Chen K , Yan W , Wu W , Yang J , Wang Q , Wang F , Zhang C , Qu J , Zhou X . Retinal dopamine D2 receptors participate in the development of myopia in mice. Invest Opthalmol Vis Sci, 2022, 63: 24.
|
20 |
Gao Q , Liu Q , Ma P , Zhong X , Wu J , Ge J . Effects of direct intravitreal dopamine injections on the development of lid-suture induced myopia in rabbits. Graefes Arch Clin Exp Ophthalmol, 2006, 244: 1329- 1335.
doi: 10.1007/s00417-006-0254-1
|
21 |
Marrocco E , Indrieri A , Esposito F , Tarallo V , Carboncino A , Alvino FG , Falco SD , Franco B , Risi MD , Leonibus ED . α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells. Sci Rep, 2020, 10: 9619.
doi: 10.1038/s41598-020-66497-6
|
22 |
RascunàC , Cicero CE , Chisari CG , Russo A , Giuliano L , Castellino N , Terravecchia C , Grillo M , Longo A , Avitabile T , Zappia M , Reibaldi M , Nicoletti A . Retinal thickness and microvascular pathway in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's disease. Parkinsonism Relat Disord, 2021, 88: 40- 45.
doi: 10.1016/j.parkreldis.2021.05.031
|
23 |
Huang L , Zhang D , Ji J , Wang Y , Zhang R . Central retina changes in Parkinson's disease: a systematic review and meta-analysis. J Neurol, 2021, 268: 4646- 4654.
doi: 10.1007/s00415-020-10304-9
|
24 |
Sen A , Tugcu B , Coskun C , Ekinci C , Nacaroglu SA . Effects of levodopa on retina in Parkinson disease. Eur J Ophthalmol, 2014, 24: 114- 119.
doi: 10.5301/ejo.5000338
|
25 |
Ucak T , Alagoz A , Cakir B , Celik E , Bozkurt E , Alagoz G . Analysis of the retinal nerve fiber and ganglion cell-inner plexiform layer by optical coherence tomography in Parkinson's patients. Parkinsonism Relat Disord, 2016, 31: 59- 64.
doi: 10.1016/j.parkreldis.2016.07.004
|
26 |
Zhao Y , Dai WJ , Liu DC . Quantitative analysis of optic disc structure and retinal nerve fiber layer thickness in patients with different degrees of Parkinson's disease. Zhonghua Yan Di Bing Za Zhi, 2020, 36: 15- 19.
doi: 10.3760/cma.j.issn.1005-1015.2020.01.004
|
|
赵颖, 戴惟葭, 刘大川. 不同程度帕金森病患者视盘参数及视网膜神经纤维层厚度定量分析. 中华眼底病杂志, 2020, 36: 15- 19.
doi: 10.3760/cma.j.issn.1005-1015.2020.01.004
|
27 |
Robbins CB , Grewal DS , Thompson AC , Soundararajan S , Yoon SP , Polascik BW , Scott BL , Fekrat S . Identifying peripapillary radial capillary plexus alterations in Parkinson's disease using OCT angiography. Ophthalmol Retina, 2022, 6: 29- 36.
doi: 10.1016/j.oret.2021.03.006
|
28 |
Murueta-Goyena A , Barrenechea M , Erramuzpe A , Teijeira-Portas S , Pengo M , Ayala U , Romero-Bascones D , Acera M , Pino RD , Gómez-Esteban JC , Gabilondo I . Foveal remodeling of retinal microvasculature in Parkinson's disease. Front Neurosci, 2021, 15: 708700.
doi: 10.3389/fnins.2021.708700
|
29 |
Kwapong WR , Ye H , Peng C , Zhuang X , Wang J , Shen M , Lu F . Retinal microvascular impairment in the early stages of Parkinson's disease. Invest Opthalmol Vis Sci, 2018, 59: 4115- 4122.
doi: 10.1167/iovs.17-23230
|
30 |
Zou J , Liu K , Li F , Xu Y , Shen L , Xu H . Combination of optical coherence tomography (OCT) and OCT angiography increases diagnostic efficacy of Parkinson's disease. Quant Imaging Med Surg, 2020, 10: 1930- 1939.
doi: 10.21037/qims-20-460
|
31 |
Deng Y , Jie C , Wang J , Liu Z , Li Y , Hou X . Evaluation of retina and microvascular changes in the patient with Parkinson's disease: a systematic review and meta-analysis. Front Med (Lausanne), 2022, 9: 957700.
|
32 |
Miri S , Shrier EM , Glazman S , Ding Y , Selesnick I , Kozlowski PB , Bodis-Wollner I . The avascular zone and neuronal remodeling of the fovea in Parkinson disease. Ann Clin Transl Neurol, 2015, 2: 196- 201.
doi: 10.1002/acn3.146
|
33 |
Invernizzi A , Carreño E , Pichi F , Munk MR , Agarwal A , Zierhut M , Pavesio C . Experts opinion: OCTA vs. FFA/ICG in uveitis, which will survive?. Ocul Immunol Inflamm, 2023, 31: 1561- 1568.
doi: 10.1080/09273948.2022.2084421
|
34 |
Robbins CB , Thompson AC , Bhullar PK , Koo HY , Agrawal R , Soundararajan S , Yoon SP , Polascik BW , Scott BL , Grewal DS , Fekrat S . Characterization of retinal microvascular and choroidal structural changes in Parkinson disease. JAMA Ophthalmol, 2021, 139: 182- 188.
doi: 10.1001/jamaophthalmol.2020.5730
|
35 |
Zhang Y , Zhang D , Gao Y , Yang L , Tao Y , Xu H , Man S , Zhang M , Xu Y . Retinal flow density changes in early-stage Parkinson's disease investigated by swept-source optical coherence tomography angiography. Curr Eye Res, 2021, 46: 1886- 1891.
doi: 10.1080/02713683.2021.1933054
|
36 |
Zhou M , Wu L , Hu Q , Wang C , Ye J , Chen T , Wan P . Visual impairments are associated with retinal microvascular density in patients with Parkinson's disease. Front Neurosci, 2021, 15: 718820.
doi: 10.3389/fnins.2021.718820
|
37 |
Price DL , Rockenstein E , Mante M , Adame A , Overk C , Spencer B , Duong-Polk KX , Bonhaus D , Lindsey J , Masliah E . Longitudinal live imaging of retinal α-synuclein: GFP deposits in a transgenic mouse model of Parkinson's disease/dementia with lewy bodies. Sci Rep, 2016, 6: 29523.
doi: 10.1038/srep29523
|
38 |
Elabi O , Gaceb A , Carlsson R , Padel T , Soylu-Kucharz R , Cortijo I , Li W , Li JY , Paul G . Human α-synuclein overexpression in a mouse model of Parkinson's disease leads to vascular pathology, blood brain barrier leakage and pericyte activation. Sci Rep, 2021, 11: 1120.
doi: 10.1038/s41598-020-80889-8
|
39 |
Chen H , Wan H , Zhang M , Liu G , Wang X , Wang Z , Huizi Ma , Pan Y , Feng T , Wang Y . Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease. Parkinsonism Relat Disord, 2021, 83: 86- 92.
doi: 10.1016/j.parkreldis.2020.12.025
|
40 |
Zhang X , Xiao H , Liu C , Liu S , Zhao L , Wang R , Wang J , Wang T , Zhu Y , Chen C , Wu X , Lin D , Qiu W , Yu-Wai-Man P , Lu Z , Lin H . Optical coherence tomography angiography reveals distinct retinal structural and microvascular abnormalities in cerebrovascular disease. Front Neurosci, 2020, 14: 588515.
doi: 10.3389/fnins.2020.588515
|
41 |
Xue C , Li X , Ba L , Zhang M , Yang Y , Gao Y , Sun Z , Han Q , Zhao RC . MSC-derived exosomes can enhance the angiogenesis of human brain MECs and show therapeutic potential in a mouse model of Parkinson's disease. Aging Dis, 2021, 12: 1211- 1222.
doi: 10.14336/AD.2020.1221
|